Page 10 - பல்கலைக்கழகம் மருத்துவ மையங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Toxys will immediately commercialize and develop further the in vitro reporter technology for mechanistic toxicity testing to improve the human safety assessment of novel medicines, chemicals and cosmetic ingredients. LEIDEN, The Netherlands, January 28, 2021 / B3C newswire / Toxys, Leiden University and Leiden University Medical Center have agreed immediately to commercialize and also develop further the ToxProfiler technology invented at the two institutions. ToxProfiler allows for rapid toxicity hazard identification of novel and existing drugs, chemicals, and other substances. Furthermore, ToxProfiler has the unique ability to provide detailed and quantitative information about the mode-of-action of such toxic substances. This new technology thereby enormously enlarges the portfolio of toxicity testing that Toxys can make available to the world, complementing the existing genotoxicity and repro-toxicity testing platforms of Toxys.

Giel hendriksPaula van rossumLeiden university medical centreLeiden academic centre of drug researchLeiden university medical centerProfessor of drug safety sciencesLeiden academic centre for drug researchLeiden universityDutch federation of university medical centresLeiden academic centreDrug researchNew approach methodScientific directorDrug safety sciencesLeiden bio scienceLeiden bio science park